eNauka - pregled

Pregled prema Projekat Alnylam

Prikaz rezultata 1 do 4 od 4
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2016Amifampridine Phosphate in patients with Lambert-Eaton myasthenic syndrome (LEMS): a phase 3, multicentre, double-blind, placebo-controlled trialSchoser, B; Oh, S; Shcherbakova, N; Kostera-Pruszczyk, A; Alsharabati, M; Dimachkie, M; Blanco, JM; Lavrnic, Dragana V; Shieh, P; Vial, C;
Meisel, Andreas; Brannagan, T; Komoly, S; Sivakumar, K; So, Y;
Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy The PARAGON-HF TrialJering, Karola K; Claggett, Brian L; Redfield, Margaret M; Shah, Sanjiv J; Anand, Inder S; Martinez, Felipe; Sabarwal, Shalini V; Seferovic, Petar M ; Saraiva, Jose F Kerr; Katova, Tzvetana;
Lefkowitz, Marty P; Pfeffer, Marc A; McMurray, John JV; Solomon, Scott D;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2025Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional OutcomesMerkel, Eperke; ...; Milasinovic, Goran; ...; (broj, koautora 17)Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2018Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2Tiede, Andreas; Janic, Dragana M  ; Ozelo, M; Santagostino, E; Korsholm, Lars; Matytsina, Irina; Lentz, SRKonferencijski rad
Mp kategorija će biti prikazana naknadno.